SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

X-energy begins irradiation testing at INL

November 12, 2025, 3:01PMNuclear News

Advanced reactor and fuel developer X-energy has officially begun confirmatory irradiation testing at Idaho National Laboratory on its TRISO-X fuel. The testing, which is taking place over the...

NRC, DOE update MOU

November 5, 2025, 7:02AMNuclear News

The Nuclear Regulatory Commission and the Department of Energy have updated a 2019 memorandum of understanding to coordinate on the review of advanced nuclear reactors and advanced reactor...